Lonnel Coats

Insider Reports History

Entity
Individual
Location
8800 Technology Forest Place, The Woodlands, TX
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Lonnel Coats
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lonnel Coats:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 1.1M $2.88M $2.62 Feb 28, 2024 Direct
Blueprint Medicines Corp Director Common Stock 13.3K $1.39M $105.13 Jun 12, 2024 Direct
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Restricted Stock Units 241K $631K $2.62 Feb 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock Option (Right to Buy) 770K Feb 8, 2024 Direct
Verve Therapeutics, Inc. Director Stock Option (right to buy) 136K Jun 26, 2024 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 4.57K Jun 12, 2024 Direct

Insider Reports Filed by Lonnel Coats

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERV Verve Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2024 7 -$161K 4 Feb 29, 2024 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Feb 8, 2024 2 $0 4 Feb 12, 2024 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Nov 16, 2023 1 $94.8K 4 Nov 17, 2023 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Nov 10, 2023 1 $10.1K 4 Nov 13, 2023 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Jun 29, 2023 1 $21.6K 4 Jun 29, 2023 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Jun 23, 2023 2 $46.7K 4 Jun 26, 2023 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Jun 22, 2023 1 $92.4K 4 Jun 22, 2023 Chief Executive Officer, Director
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $5.3K 4 Jun 23, 2023 Director
VERV Verve Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2023 7 -$111K 4 Mar 1, 2023 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Feb 9, 2023 2 $0 4 Feb 13, 2023 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Aug 8, 2022 1 $0 4 Aug 9, 2022 Director
VERV Verve Therapeutics, Inc. Aug 8, 2022 0 $0 3 Aug 9, 2022 Director
BPMC Blueprint Medicines Corp Jun 21, 2022 2 $0 4 Jun 30, 2022 Director
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2022 7 -$137K 4 Feb 28, 2022 Chief Executive Officer, Director
LXRX LEXICON PHARMACEUTICALS, INC. Feb 10, 2022 2 $0 4 Feb 14, 2022 Chief Executive Officer, Director
BPMC Blueprint Medicines Corp Jun 2, 2021 2 $0 4 Jun 4, 2021 Director